Support of existing Low Density Lipid (LDL) Removal Apheresis Systems
A Contract Award Notice
by NHS BLOOD AND TRANSPLANT
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 2 year
- Value
- £100K-£141K
- Sector
- HEALTH
- Published
- 18 Feb 2026
- Delivery
- 20 Jan 2026 to 19 Jan 2028
- Deadline
- 31 Aug 2025 11:00
Related Terms
Location
Geochart for 1 buyers and 1 suppliers
1 buyer
- NHS Blood & Transplant Bristol
1 supplier
- Fresenius Medical Care Sutton in Ashfield
Description
NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales. Requirement for support of existing Low Density Lipid (LDL) Removal Apheresis Systems.
Award Detail
| 1 | Fresenius Medical Care (Sutton in Ashfield)
|
CPV Codes
- 50420000 - Repair and maintenance services of medical and surgical equipment
Reference
- CF-3393300D0O000000rwimUAA
- CF 603215cd-b4a4-4372-9470-041aab34ce01